Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone for Cognitive Enhancement in Schizophrenia
NCT06387771Phase 2Recruiting
- Sponsor
- Universidad de Navarra
- Start
- Sep 2014
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolcapone in schizophrenia, sponsored by Universidad de Navarra. Started Sep 2014; status: recruiting.
02
Drugs
tolcapone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06387771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06387771.